Accumulating Evidence for Reduced-Dose Thrombolysis in Acute Pulmonary Embolism*
Author:
Affiliation:
1. Pulmonary, Allergy, Critical Care, and Sleep Medicine Division, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
2. General Intensive Care Unit, St George’s Hospital, London, United Kingdom.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference14 articles.
1. Contemporary anticoagulant treatment strategies in patients with acute pulmonary embolism at different risk for death.;Becattini;Vascul Pharmacol,2023
2. Anti-factor Xa as the preferred assay to monitor heparin for the treatment of pulmonary embolism.;Zhu;Int J Lab Hematol,2023
3. Usefulness of a refined computed tomography imaging method to assess the prevalence of residual pulmonary thrombi in patients 1 year after acute pulmonary embolism: The Nagoya PE study.;Nakano;J Thromb Haemost,2022
4. Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: Comparison of computed tomography and perfusion scintigraphy.;van Es;J Thromb Haemost,2013
5. Thrombolytic therapy for pulmonary embolism.;Zuo;Cochrane Database Syst Rev,2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3